Cargando…

487. Experience with Remdesivir for Treatment of SARS-CoV-2 in Patients with Liver Cirrhosis

BACKGROUND: Remdesivir is a nucleotide analogue antiviral that was FDA approved for the treatment of hospitalized patients with coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS CoV-2). Remdesivir has been associated with elevations in serum aminotra...

Descripción completa

Detalles Bibliográficos
Autores principales:	Saunders-Hao, Patricia, Jain, Sumeet, Hirsch, Bruce, Gautam-Goyal, Pranisha
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2021
Materias:	Poster Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8643756/ http://dx.doi.org/10.1093/ofid/ofab466.686

Ejemplares similares

1215. The Impact of MRSA Nasal PCR on Antibiotic De-escalation
por: Silverman, Adam, et al.
Publicado: (2023)

1364. Association Between Tixagevimab/Cilgavimab Administration and Self-Reported SARS-CoV-2 Infection During the Omicron Surge
por: Mathew, Daniya S, et al.
Publicado: (2023)

628. Utilizing Cefepime Therapeutic Drug Monitoring for Patients at Risk of or Exhibiting Signs of Neurotoxicity
por: Au, Joanna, et al.
Publicado: (2022)

197. The Clinical Impact of Early Detection of ESBL-Producing Enterobacterales with PCR-Based Blood Culture Assays
por: Chang, Kai-Ming, et al.
Publicado: (2022)

487. Patient Outcomes of Contact Tracing for COVID-19 in a Pediatric Hospital
por: Smathers, Sarah, et al.
Publicado: (2020)

539. Impact of Corticosteroids when Combined with Tocilizumab or Remdesivir for the Treatment of Severe SARS-CoV-2
por: Rosati, Michael, et al.
Publicado: (2021)

972. Antimicrobial Stewardship Educational Needs of Residents in an Internal Medicine Program
por: Kennedy, Jessica, et al.
Publicado: (2021)

505. Impact of Remdesivir on SARS-CoV-2 Clearance in a Real-Life Setting: A Matched-Cohort Study
por: Spagnuolo, Vincenzo, et al.
Publicado: (2021)

534. The Use of Tocilizumab and Remdesivir in SARS- CoV-2 Patients in El Paso Texas: A Longitudinal Comparative Observational Study
por: Almaghlouth, Nouf K, et al.
Publicado: (2021)

507. Impact of Baricitinib on Outcomes in Patients Treated with Remdesivir and Dexamethasone for SARS-CoV-2 Pneumonia: A Retrospective Cohort Study
por: Dea, Lauren, et al.
Publicado: (2021)

Outpatient Treatment with Anti-Sars-Cov-2 Monoclonal Antibodies and Remdesivir for COVID19 Infections Demonstrates Encouraging Outcomes in Hematopoietic Stem Cell Transplant Recipients: A Single-Center Experience
por: Ionescu, Filip, et al.
Publicado: (2022)

1997. Impact of Blood Culture Fill Volumes
por: Berlinrut, Ilan, et al.
Publicado: (2018)

72. Remdesivir vs Standard Care in Patients with Moderate covid-19
por: Marty, Francisco M, et al.
Publicado: (2020)

545. Remdesivir And Obeldesivir Retain Potent Activity Against SARS-CoV-2 Omicron Variants
por: Rodriguez, Lauren, et al.
Publicado: (2023)

487. Severity and Clinical Outcomes of Clostridium difficile Infection Based on Toxin B Assay Results
por: Kamimoto, Jorge Jo, et al.
Publicado: (2018)

557. Trends in Remdesivir Treatment Over the Course of the COVID-19 Pandemic
por: Xin Liao, J, et al.
Publicado: (2021)

561. Safety of Remdesivir vs Standard Care in Patients with Moderate Covid-19
por: Criner, Gerard J, et al.
Publicado: (2020)

555. Utilization of Remdesivir for COVID-19 in the National Veterans Affairs Healthcare System
por: Caffrey, Aisling, et al.
Publicado: (2021)

540. Does Remdesivir Impact the Clinical Outcome of Patients with COVID 19 Infection?
por: Gunasekaran, Karthik, et al.
Publicado: (2021)

PM487. Presynaptic protein Piccolo knockdown in the prefrontal cortex induces cognitive and emotional impairment in mice.
por: Miyamoto, Yoshiaki, et al.
Publicado: (2016)

Remdesivir in Patients With Estimated GFR <30 ml/min per 1.73 m(2) or on Renal Replacement Therapy
por: Estiverne, Christopher, et al.
Publicado: (2020)

551. Remdesivir and Tocilizumab for the Treatment of Severe COVID-19 in a Community Hospital: A Retrospective Cohort Study
por: Rodriguez-Nava, Guillermo, et al.
Publicado: (2021)

487 Safety of Sublingual Immunotherapy with Standardized Vaccines of Domestic Mites
por: Alvarez, Mirta, et al.
Publicado: (2012)

73. Geographical Disparities in Clinical Outcomes of Severe COVID-19 Patients Treated with Remdesivir
por: Diaz, George, et al.
Publicado: (2020)

527. Lower Risk of ICU Admission with Remdesivir in Patients Hospitalized with COVID-19 Pneumonia
por: Lim, Sarah, et al.
Publicado: (2021)

557. Impact of Concomitant Hydroxychloroquine Use on Safety and Efficacy of Remdesivir in Moderate COVID-19 Patients
por: Arribas, Jose Ramon, et al.
Publicado: (2020)

Liver and Renal Injury with Remdesivir Treatment in SARS-CoV-2 Patients
por: Sadaf, Rabiah, et al.
Publicado: (2023)

315. Standardized Measurement of SARS-CoV-2 Viral Load Over Time in Respiratory Compartments and in Response to Remdesivir Treatment
por: Beckwith, Curt, et al.
Publicado: (2022)

Early experience with remdesivir in SARS-CoV-2 pneumonia
por: Durante-Mangoni, Emanuele, et al.
Publicado: (2020)

821. Changes in Cleaning Practices and Non-conventional Personal Protective Equipment Use due to SARS-CoV-2 and Association with Increases in Multi-drug Resistant Organism Cases
por: Witwer, Medora L, et al.
Publicado: (2021)

487. Prevalence of Antimicrobial Resistance in Gram-Negative Bacilli Bloodstream Infections at a Tertiary Teaching Hospital in the Dominican Republic
por: Mena Lora, Alfredo J, et al.
Publicado: (2019)

487 Evaluating use of doxycycline versus vancomycin for treatment of methicillin-resistant Staphylococcus aureus–associated acute pulmonary exacerbations in people with cystic fibrosis
por: Brickel, K., et al.
Publicado: (2022)

A case of Listeria monocytogenes meningitis complicated by Hydrocephalus and Intraventricular hemorrhage: A review of treatment options and outcomes
por: Gerstein, Shawn, et al.
Publicado: (2020)

536. Clinical Outcomes of Hospitalized COVID-19 Patients Treated with Remdesivir-NEAT ID 909REM Study
por: Raffi, François, et al.
Publicado: (2021)

524. Assessing the Safety of an Outpatient Remdesivir Infusion Program for Patients with Severe COVID-19 in the Setting of a Pandemic Surge
por: Gee, Benjamin, et al.
Publicado: (2021)

882. Evaluating the Risk Factors in Postoperative Infections Following Hysterectomy Procedures: Is Antibiotic Prophylaxis the Issue?
por: Yi, Stacie, et al.
Publicado: (2020)

Therapeutic Efficacy and Outcomes of Remdesivir versus Remdesivir with Tocilizumab in Severe SARS-CoV-2 Infection
por: Vulturar, Damiana-Maria, et al.
Publicado: (2022)

487 Infections Caused by Enterobacteriaceae Species following Cardiac Surgery: Impact of Polymyxin Resistance on Treatment Outcomes
por: Abboud, Cely Saad, et al.
Publicado: (2014)

1605. Differences in Clinical Characteristics of Third Generation Cephalosporin Resistance and Treatment Outcomes in Escherichia coli and Klebsiella pneumoniae Bacteremia in Patients with Liver Cirrhosis
por: Ham, Sin Young, et al.
Publicado: (2020)

Adult onset immunoglobulin A vasculitis (Henoch-Schonlein purpura) with alveolar hemorrhage
por: Niknam, Negin, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_r60lhtf3k4553m1p1hh3s0vurn